Melanoma Stage III
Oncology
5
Pipeline Programs
5
Companies
5
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
5
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
150%
Monoclonal Antibody
150%
+ 3 programs with unclassified modality
Competitive Landscape
5 companies ranked by most advanced pipeline stage
Pierre FabreFrance - Aignan
1 program1
Encorafenib + BinimetinibPhase 2Small Molecule1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
Bristol Myers SquibbNivolumab
Pierre FabreEncorafenib + Binimetinib
RegeneronBNT111
AmgenT-VEC
AmgenT-VEC
Clinical Trials (5)
Total enrollment: 304 patients across 5 trials
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
Start: May 2024Est. completion: Nov 202890 patients
Phase 2Recruiting
(Neo)Adjuvant BRAF/MEK Inhibition in pN1c Melanoma
Start: Jan 2022Est. completion: Jan 2026
Phase 2Unknown
A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment
Start: May 2021Est. completion: Nov 2025184 patients
Phase 2Completed
Neo-adjuvant T-VEC + Nivolumab Combination Therapy for Resectable Early Metastatic (stage IIIB/C/D-IV M1a) Melanoma with Injectable Disease
Start: Sep 2020Est. completion: Jan 202524 patients
Phase 2Completed
Neoadjuvant T-VEC in High Risk Early Melanoma
Start: May 2020Est. completion: May 20246 patients
Phase 2Suspended
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
1h ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
1h ago
Office Administrator
SystImmune
1h ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
2h ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
2h ago
Working Student Active Sourcing Support (m/f/d)
Mindpeak
Hamburg
2h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 304 patients
5 companies competing in this space